B.O.S.S. Retirement Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,998
Closed -$280K 198
2025
Q3
$280K Sell
10,998
-452
-4% -$11.2K 0.07% 159
2025
Q2
$278K Buy
11,450
+543
+5% +$12.7K 0.07% 155
2025
Q1
$276K Sell
10,907
-561
-5% -$14.7K 0.08% 146
2024
Q4
$304K Sell
11,468
-73,584
-87% -$2M 0.09% 140
2024
Q3
$2.46M Buy
85,052
+11,558
+16% +$337K 0.5% 55
2024
Q2
$2.06M Buy
73,494
+40,947
+126% +$1.13M 0.53% 58
2024
Q1
$937K Sell
32,547
-5,332
-14% -$148K 0.36% 99
2023
Q4
$1.09M Sell
37,879
-3,298
-8% -$99.7K 0.21% 150
2023
Q3
$1.37M Sell
41,177
-4,241
-9% -$150K 0.29% 129
2023
Q2
$1.67M Sell
45,418
-693
-2% -$27K 0.35% 106
2023
Q1
$1.88M Buy
46,111
+4,162
+10% +$180K 0.44% 86
2022
Q4
$2.15M Buy
+41,949
New +$2.01M 0.55% 60

Other funds holding PFE

B.O.S.S. Retirement Advisors's PFE Position: Q4 2025 in Review

B.O.S.S. Retirement Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 10,998 shares — an estimated $280K sold.

B.O.S.S. Retirement Advisors first reported a position in PFE in Q4 2022 and held it in 12 quarters. The position peaked at $2.46M in Q3 2024. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • B.O.S.S. Retirement Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • B.O.S.S. Retirement Advisors sold 10,998 Pfizer shares in Q4 2025, an estimated $280K.
  • B.O.S.S. Retirement Advisors first reported a position in Pfizer in Q4 2022 and held it in 12 quarters.
  • B.O.S.S. Retirement Advisors's Pfizer position peaked at $2.46M in Q3 2024.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on B.O.S.S. Retirement Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.